Albany, New York Clinical Trials

A listing of Albany, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 42 clinical trials
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

CALAVI US will investigate the safety, efficacy and pharmacokinetics of acalabrutinib together with Best Supportive Care in the treatment of COVID-19.

covid-19
oximetry
acalabrutinib
acute respiratory syndrome (sars)
pneumonia
Research Site
 (2.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

Opaganib, a sphingosine kinase-2 (SphK2) inhibitor, has been broadly tested in Phase I/II studies. Extensive nonclinical data indicates both anti-viral and anti-inflammatory activity via selective SphK2 inhibition which may prove beneficial for treating COVID-19 infection and resulting pneumonia. This proof of concept study will take place in the US and …

covid-19
x-rays
chest x-ray
pneumonia
opaganib
Albany Medical Center
 (1.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

tirzepatide
cardiovascular disease
body mass index
dulaglutide
Endocrine Group, LLP
 (2.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +650 other locations
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

This is a Phase 2, randomized, multicenter, double-blind study of the glutaminase inhibitor telaglenastat with standard-of-care pembrolizumab and chemotherapy versus placebo with standard-of-care pembrolizumab and chemotherapy for first line treatment of metastatic disease in patients with KEAP1/NRF2-mutated, stage IV, nonsquamous, non-small cell lung cancer (NSCLC). The study primary endpoints are …

STK11
systemic therapy
pemetrexed
measurable disease
adjuvant
New York Oncology Hematology, P.C. (43 New Scotland Ave.)
 (1.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +27 other locations
No Opioids PrescrIptions On Discharge After Surgery

Opioid analgesics are routinely prescribed for these patients for post-operative pain control. Even a short exposure to opioids in opioid-nave patients following minor or major surgery has been associated with de novo habitual or persistent use of opioids in 5-30% of patients. The goal of the study to eliminate the …

nephrectomy
partial nephrectomy
urologic surgery
radical cystectomy
opioid
Albany Medical Center
 (1.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
PCOS Treatment Using DLBS3233, Metformin, and Combination of Both (POSITIF)  

This is a 3-arm, randomized, double-blind, double-dummy, and controlled clinical study over 6 months of treatment to evaluate the metabolic and clinical efficacy as well as the safety of DLBS3233 alone, metformin and combination of both, in improving metabolic and reproductive parameters.

PCOS Treatment Trial
 (5.1 away)
  • 0 views
  • 26 Oct, 2022
  • +3 other locations
PCOS Treatment Using DLBS3233 and Metformin.

This is a 3-arm, randomized, double-blind, double-dummy, and controlled clinical study over 6 months of treatment to evaluate the metabolic and clinical efficacy as well as the safety of DLBS3233 alone, metformin and combination of both, in improving metabolic and reproductive parameters.

PCOS Treatment Trial
 (5.1 away) Contact site
  • 0 views
  • 23 Sep, 2022
  • +2 other locations
Test

This is a 3-arm, randomized, double-blind, double-dummy, and controlled clinical study over 6 months of treatment to evaluate the metabolic and clinical efficacy as well as the safety of DLBS3233 alone, metformin and combination of both, in improving metabolic and reproductive parameters.

test 1
 (5.1 away) Contact site
  • 0 views
  • 26 Sep, 2022
  • +2 other locations
Study Test Site  

This is a 3-arm, randomized, double-blind, double-dummy, and controlled clinical study over 6 months of treatment to evaluate the metabolic and clinical efficacy as well as the safety of DLBS3233 alone, metformin and combination of both, in improving metabolic and reproductive parameters.

test 1
 (5.1 away)
  • 0 views
  • 28 Sep, 2022
  • +1 other locations
Hypertension Management in Family Practice  

High blood pressure is the greatest threat to the global burden of disease, contributing to an estimated 9.4 million deaths a year. Cardiovascular disease morbidity and mortality are positively correlated with the degree of elevation of blood pressure, without any evidence of a threshold down to at least 115/75 mm …

Online studies
Test Site 002
 (0.0 away)
  • 0 views
  • 08 Nov, 2022
  • +2 other locations